• linkedin
  • Increase Font
  • Sharebar

    A new standard of care in muscle-invasive bladder Ca?

    With a median follow-up of almost a decade, patients with muscle-invasive bladder cancer who had chemoradiotherapy had improved locoregional control and a reduced salvage cystectomy rate compared to those who had radiotherapy alone, according to research presented at the Genitourinary Cancers Symposium, Orlando, FL.

    Chemoradiotherapy, with fluorouracil (5FU) and mitomycin, should be a standard of care for these patients, the study authors say.

    Also see: A new standard of care in muscle-invasive bladder Ca?

    The take-home message to urologists from the Cancer Research UK-funded phase III trial, according to co-lead author Professor Emma Hall, PhD, of the Institute of Cancer Research, London, is that chemoradiotherapy is an effective alternative to cystectomy in the primary management of muscle-invasive bladder cancer.

    “Patients preserve their bladder and have good long-term quality of life outcomes,” she said.

    Dr. Hall and colleagues studied 458 patients with muscle-invasive bladder cancer who received radiotherapy or chemoradiotherapy, and, for the radiotherapy comparison, standard radiotherapy versus reduced high-dose volume radiotherapy.

    Next: 2-year salvage cystectomy rate 11% in the chemoradiotherapy group, compared to 17% among those on radiotherapy only

    Lisette Hilton
    Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available